High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH
- 25 July 2007
- journal article
- research article
- Published by Springer Nature in The Esophagus
- Vol. 42 (7), 573-582
- https://doi.org/10.1007/s00535-007-2060-x
Abstract
The changes in nonalcoholic fatty liver disease (NAFLD) range over a wide spectrum, extending from steatosis to steatohepatitis (NASH). However, it has remained difficult to differentiate between NASH and nonprogressive NAFLD by clinical examination. We investigated the interrelationships between serum high-sensitivity C-reactive protein (hs-CRP) and the pathogenesis and progression of NASH.Keywords
This publication has 47 references indexed in Scilit:
- Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2Journal of Hepatology, 2006
- C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring StudyCirculation, 2004
- A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis† ‡Hepatology, 2004
- Long–Term Outcomes of Cirrhosis in Nonalcoholic Steatohepatitis Compared With Hepatitis CHepatology, 2003
- Non‐alcoholic fatty liver diseaseJournal of Gastroenterology and Hepatology, 2002
- NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndromeHepatology, 2002
- Relationship between Visceral Fat Accumulation and Anti-Lipolytic Action of Insulin in Patients with Type 2 Diabetes Mellitus.Endocrine Journal, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆Gastroenterology, 1999
- C-Reactive Protein in Healthy Subjects: Associations With Obesity, Insulin Resistance, and Endothelial DysfunctionArteriosclerosis, Thrombosis, and Vascular Biology, 1999